The cancer drugs called PARP inhibitors have a puzzling reputation: even though they are treatment mainstays for multiple forms of cancer, they can damage cancer-killing T cells and disrupt the ...

That DNA damage is particularly prominent in people who developed colorectal cancer at a younger age, researchers at the University of California San Diego said Wednesday. The new study sequenced ...